|
Market Closed -
Nasdaq
07:00:00 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.370 USD | +2.12% |
|
+10.13% | +76.44% |
| Market Cap | 415M 371M 342M 309M 578M 39.37B 589M 4.07B 1.64B 20.71B 1.56B 1.52B 65.3B | P/E 2026 * |
-4.02x | P/E 2027 * | -3.68x |
|---|---|---|---|---|---|
| Enterprise Value | 333M 299M 275M 249M 465M 31.65B 474M 3.27B 1.31B 16.65B 1.25B 1.22B 52.5B | EV / Sales 2026 * |
12.7x | EV / Sales 2027 * | 13.3x |
| Free-Float |
99.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CCCC | Delayed | |
CBOE
| CCCC | Real-time |
Last Transcript: C4 Therapeutics, Inc.
| 1 day | +2.12% | ||
| 1 week | +10.13% | ||
| Current month | +1.20% | ||
| 1 month | +1.20% | ||
| 3 months | -7.92% | ||
| 6 months | +19.08% | ||
| Current year | +76.44% |
| 1 week | 2.94 | 3.53 | |
| 1 month | 2.59 | 3.53 | |
| Current year | 1.69 | 5.17 | |
| 1 year | 1.69 | 5.17 | |
| 3 years | 1.06 | 11.88 | |
| 5 years | 1.06 | 48.75 | |
| 10 years | 1.06 | 51.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 55 | 02/10/2020 |
Kendra Adams
DFI | Director of Finance/CFO | 49 | 18/09/2023 |
Paige Mahaney
CTO | Chief Tech/Sci/R&D Officer | 56 | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenneth Anderson
BRD | Director/Board Member | 74 | 01/12/2015 |
Andrew Hirsch
BRD | Director/Board Member | 55 | 14/09/2020 |
Utpal Koppikar
BRD | Director/Board Member | 55 | 16/03/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Free | Founder | 3,662 | 0.0030% | ||
| 1/10/26 | Free | Director | 4,618 | 0.0038% | ||
| 18/9/26 | Exercice | Chief Financial Officer | 9,025 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.12% | +10.13% | +36.99% | +123.18% | 415M | ||
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | ||
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | ||
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | ||
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | ||
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | ||
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | ||
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | ||
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | ||
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | ||
| Average | +0.52% | +7.80% | +46.77% | +198.01% | 39.48B | |
| Weighted average by Cap. | +0.18% | +5.45% | +48.49% | +186.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.32M 23.57M 21.68M 19.64M 36.72M 2.5B 37.41M 259M 104M 1.31B 98.77M 96.67M 4.15B | 22.43M 20.09M 18.48M 16.74M 31.29M 2.13B 31.88M 220M 88.45M 1.12B 84.17M 82.38M 3.53B |
| Net income | -111M -99.29M -91.33M -82.75M -155M -10.53B -158M -1.09B -437M -5.54B -416M -407M -17.46B | -141M -126M -116M -105M -196M -13.37B -200M -1.38B -555M -7.03B -529M -517M -22.18B |
| Net Debt | -81.29M -72.8M -66.97M -60.68M -113M -7.72B -116M -799M -321M -4.06B -305M -299M -12.8B | -117M -105M -96.51M -87.45M -163M -11.12B -167M -1.15B -462M -5.85B -440M -430M -18.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | USD 3.370 | +2.12% | 2,354,093 |
| 29/10/26 | USD 3.300 | -2.80% | 2,715,031 |
| 28/10/26 | USD 3.395 | +5.76% | 4,110,813 |
| 27/10/26 | USD 3.210 | +7.72% | 4,119,734 |
| 26/10/26 | USD 2.980 | -2.61% | 3,179,137 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CCCC Stock
Select your edition
All financial news and data tailored to specific country editions

















